{"pmid":32306500,"title":"Supporting pandemic response using genomics and bioinformatics: a case study on the emergent SARS-CoV-2 outbreak.","text":["Supporting pandemic response using genomics and bioinformatics: a case study on the emergent SARS-CoV-2 outbreak.","Pre-clinical responses to fast moving infectious disease outbreaks heavily depend on choosing the best isolates for animal models that inform diagnostics, vaccines and treatments. Current approaches are driven by practical considerations (e.g. first available virus isolate) rather than a detailed analysis of the characteristics of the virus strain chosen, which can lead to animal models that are not representative of the circulating or emerging clusters. Here, we suggest a combination of epidemiological, experimental and bioinformatics considerations when choosing virus strains for animal model generation. We discuss the currently chosen SARS-CoV-2 strains for international coronavirus disease (COVID-19) models in the context of their phylogeny as well as in a novel alignment-free bioinformatics approach. Unlike phylogenetic trees, which focus on individual shared mutations, this new approach assesses genome-wide co-developing functionalities and hence offers a more fluid view of the \"cloud of variances\" that RNA viruses are prone to accumulate. This joint approach concludes that while the current animal models cover the existing viral strains adequately, there is substantial evolutionary activity that is likely not considered by the current models. Based on insights from the non-discrete alignment-free approach and experimental observations, we suggest isolates for future animal models.","Transbound Emerg Dis","Bauer, Denis C","Tay, Aidan P","Wilson, Laurence O W","Reti, Daniel","Hosking, Cameron","McAuley, Alexander J","Pharo, Elizabeth","Todd, Shawn","Stevens, Vicky","Neave, Matthew J","Tachedjian, Mary","Drew, Trevor W","Vasan, S S","32306500"],"abstract":["Pre-clinical responses to fast moving infectious disease outbreaks heavily depend on choosing the best isolates for animal models that inform diagnostics, vaccines and treatments. Current approaches are driven by practical considerations (e.g. first available virus isolate) rather than a detailed analysis of the characteristics of the virus strain chosen, which can lead to animal models that are not representative of the circulating or emerging clusters. Here, we suggest a combination of epidemiological, experimental and bioinformatics considerations when choosing virus strains for animal model generation. We discuss the currently chosen SARS-CoV-2 strains for international coronavirus disease (COVID-19) models in the context of their phylogeny as well as in a novel alignment-free bioinformatics approach. Unlike phylogenetic trees, which focus on individual shared mutations, this new approach assesses genome-wide co-developing functionalities and hence offers a more fluid view of the \"cloud of variances\" that RNA viruses are prone to accumulate. This joint approach concludes that while the current animal models cover the existing viral strains adequately, there is substantial evolutionary activity that is likely not considered by the current models. Based on insights from the non-discrete alignment-free approach and experimental observations, we suggest isolates for future animal models."],"journal":"Transbound Emerg Dis","authors":["Bauer, Denis C","Tay, Aidan P","Wilson, Laurence O W","Reti, Daniel","Hosking, Cameron","McAuley, Alexander J","Pharo, Elizabeth","Todd, Shawn","Stevens, Vicky","Neave, Matthew J","Tachedjian, Mary","Drew, Trevor W","Vasan, S S"],"date":"2020-04-20T11:00:00Z","year":2020,"_id":"32306500","week":"202017|Apr 20 - Apr 26","doi":"10.1111/tbed.13588","keywords":["alignment-free phylogeny","bioinformatics","covid-19","genomics","pheic","viral evolution"],"source":"PubMed","topics":["Mechanism"],"weight":1,"_version_":1664641855764037634,"score":8.518259,"similar":[{"pmid":32209231,"pmcid":"PMC7094376","title":"Computers and viral diseases. Preliminary bioinformatics studies on the design of a synthetic vaccine and a preventative peptidomimetic antagonist against the SARS-CoV-2 (2019-nCoV, COVID-19) coronavirus.","text":["Computers and viral diseases. Preliminary bioinformatics studies on the design of a synthetic vaccine and a preventative peptidomimetic antagonist against the SARS-CoV-2 (2019-nCoV, COVID-19) coronavirus.","This paper concerns study of the genome of the Wuhan Seafood Market isolate believed to represent the causative agent of the disease COVID-19. This is to find a short section or sections of viral protein sequence suitable for preliminary design proposal for a peptide synthetic vaccine and a peptidomimetic therapeutic, and to explore some design possibilities. The project was originally directed towards a use case for the Q-UEL language and its implementation in a knowledge management and automated inference system for medicine called the BioIngine, but focus here remains mostly on the virus itself. However, using Q-UEL systems to access relevant and emerging literature, and to interact with standard publically available bioinformatics tools on the Internet, did help quickly identify sequences of amino acids that are well conserved across many coronaviruses including 2019-nCoV. KRSFIEDLLFNKV was found to be particularly well conserved in this study and corresponds to the region around one of the known cleavage sites of the SARS virus that are believed to be required for virus activation for cell entry. This sequence motif and surrounding variations formed the basis for proposing a specific synthetic vaccine epitope and peptidomimetic agent. The work can, nonetheless, be described in traditional bioinformatics terms, and readily reproduced by others, albeit with the caveat that new data and research into 2019-nCoV is emerging and evolving at an explosive pace. Preliminary studies using molecular modeling and docking, and in that context the potential value of certain known herbal extracts, are also described.","Comput Biol Med","Robson, B","32209231"],"abstract":["This paper concerns study of the genome of the Wuhan Seafood Market isolate believed to represent the causative agent of the disease COVID-19. This is to find a short section or sections of viral protein sequence suitable for preliminary design proposal for a peptide synthetic vaccine and a peptidomimetic therapeutic, and to explore some design possibilities. The project was originally directed towards a use case for the Q-UEL language and its implementation in a knowledge management and automated inference system for medicine called the BioIngine, but focus here remains mostly on the virus itself. However, using Q-UEL systems to access relevant and emerging literature, and to interact with standard publically available bioinformatics tools on the Internet, did help quickly identify sequences of amino acids that are well conserved across many coronaviruses including 2019-nCoV. KRSFIEDLLFNKV was found to be particularly well conserved in this study and corresponds to the region around one of the known cleavage sites of the SARS virus that are believed to be required for virus activation for cell entry. This sequence motif and surrounding variations formed the basis for proposing a specific synthetic vaccine epitope and peptidomimetic agent. The work can, nonetheless, be described in traditional bioinformatics terms, and readily reproduced by others, albeit with the caveat that new data and research into 2019-nCoV is emerging and evolving at an explosive pace. Preliminary studies using molecular modeling and docking, and in that context the potential value of certain known herbal extracts, are also described."],"journal":"Comput Biol Med","authors":["Robson, B"],"date":"2020-03-27T11:00:00Z","year":2020,"_id":"32209231","week":"202013|Mar 23 - Mar 29","doi":"10.1016/j.compbiomed.2020.103670","keywords":["2019-ncov coronavirus","automatic browser","bioinformatics","peptidomimetic","q-uel language","retroinverso","synthetic vaccine","wuhan seafood market coronavirus"],"source":"PubMed","topics":["Mechanism","Treatment"],"weight":1,"locations":["Q-UEL"],"_version_":1664638933365948416,"score":235.59044},{"pmid":32300673,"pmcid":"PMC7161481","title":"Genomic characterization of a novel SARS-CoV-2.","text":["Genomic characterization of a novel SARS-CoV-2.","A new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) associated with human to human transmission and extreme human sickness has been as of late announced from the city of Wuhan in China. Our objectives were to mutation analysis between recently reported genomes at various times and locations and to characterize the genomic structure of SARS-CoV-2 using bioinformatics programs. Information on the variation of viruses is of considerable medical and biological impacts on the prevention, diagnosis, and therapy of infectious diseases. To understand the genomic structure and variations of the SARS-CoV-2. The study analyzed 95 SARS-CoV-2 complete genome sequences available in GenBank, National MicrobiologyData Center (NMDC) and NGDC Genome Warehouse from December-2019 until 05 of April-2020. The genomic signature analysis demonstrates that a strong association between the time of sample collection, location of sample and accumulation of genetic diversity. We found 116 mutations, the three most common mutations were 8782C>T in ORF1ab gene, 28144T>C in ORF8 gene and 29095C>T in the N gene. The mutations might affect the severity and spread of the SARS-CoV-2. The finding heavily supports an intense requirement for additional prompt, inclusive investigations that combine genomic detail, epidemiological information and graph records of the clinical features of patients with COVID-19.","Gene Rep","Khailany, Rozhgar A","Safdar, Muhamad","Ozaslan, Mehmet","32300673"],"abstract":["A new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) associated with human to human transmission and extreme human sickness has been as of late announced from the city of Wuhan in China. Our objectives were to mutation analysis between recently reported genomes at various times and locations and to characterize the genomic structure of SARS-CoV-2 using bioinformatics programs. Information on the variation of viruses is of considerable medical and biological impacts on the prevention, diagnosis, and therapy of infectious diseases. To understand the genomic structure and variations of the SARS-CoV-2. The study analyzed 95 SARS-CoV-2 complete genome sequences available in GenBank, National MicrobiologyData Center (NMDC) and NGDC Genome Warehouse from December-2019 until 05 of April-2020. The genomic signature analysis demonstrates that a strong association between the time of sample collection, location of sample and accumulation of genetic diversity. We found 116 mutations, the three most common mutations were 8782C>T in ORF1ab gene, 28144T>C in ORF8 gene and 29095C>T in the N gene. The mutations might affect the severity and spread of the SARS-CoV-2. The finding heavily supports an intense requirement for additional prompt, inclusive investigations that combine genomic detail, epidemiological information and graph records of the clinical features of patients with COVID-19."],"journal":"Gene Rep","authors":["Khailany, Rozhgar A","Safdar, Muhamad","Ozaslan, Mehmet"],"date":"2020-04-18T11:00:00Z","year":2020,"_id":"32300673","week":"202016|Apr 13 - Apr 19","doi":"10.1016/j.genrep.2020.100682","keywords":["blast, basic local alignment search tool","cdc, centers of disease control and prevention","covid-19","covid-19, coronavirus disease 2019","emboss, the european molecular biology open software suite","genomic characterization","mers, middle east respiratory syndrome","mutation","ncbi, national center for biotechnology information","ngdc, national genomics data center","nmdc, national microbiology data center","nsp, nonstructural protein","orf, open reading frame","sars-cov-2","sars-cov-2, severe acute respiratory syndrome coronavirus 2","utr, untranslated region","who, world health organization"],"source":"PubMed","topics":["Mechanism"],"weight":1,"locations":["Wuhan","China"],"countries":["China"],"countries_codes":["CHN|China"],"_version_":1664635401252372480,"score":229.77405},{"pmid":31987001,"pmcid":"PMC7067204","title":"Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan.","text":["Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan.","A mysterious outbreak of atypical pneumonia in late 2019 was traced to a seafood wholesale market in Wuhan of China. Within a few weeks, a novel coronavirus tentatively named as 2019 novel coronavirus (2019-nCoV) was announced by the World Health Organization. We performed bioinformatics analysis on a virus genome from a patient with 2019-nCoV infection and compared it with other related coronavirus genomes. Overall, the genome of 2019-nCoV has 89% nucleotide identity with bat SARS-like-CoVZXC21 and 82% with that of human SARS-CoV. The phylogenetic trees of their orf1a/b, Spike, Envelope, Membrane and Nucleoprotein also clustered closely with those of the bat, civet and human SARS coronaviruses. However, the external subdomain of Spike's receptor binding domain of 2019-nCoV shares only 40% amino acid identity with other SARS-related coronaviruses. Remarkably, its orf3b encodes a completely novel short protein. Furthermore, its new orf8 likely encodes a secreted protein with an alpha-helix, following with a beta-sheet(s) containing six strands. Learning from the roles of civet in SARS and camel in MERS, hunting for the animal source of 2019-nCoV and its more ancestral virus would be important for understanding the origin and evolution of this novel lineage B betacoronavirus. These findings provide the basis for starting further studies on the pathogenesis, and optimizing the design of diagnostic, antiviral and vaccination strategies for this emerging infection.","Emerg Microbes Infect","Chan, Jasper Fuk-Woo","Kok, Kin-Hang","Zhu, Zheng","Chu, Hin","To, Kelvin Kai-Wang","Yuan, Shuofeng","Yuen, Kwok-Yung","31987001"],"abstract":["A mysterious outbreak of atypical pneumonia in late 2019 was traced to a seafood wholesale market in Wuhan of China. Within a few weeks, a novel coronavirus tentatively named as 2019 novel coronavirus (2019-nCoV) was announced by the World Health Organization. We performed bioinformatics analysis on a virus genome from a patient with 2019-nCoV infection and compared it with other related coronavirus genomes. Overall, the genome of 2019-nCoV has 89% nucleotide identity with bat SARS-like-CoVZXC21 and 82% with that of human SARS-CoV. The phylogenetic trees of their orf1a/b, Spike, Envelope, Membrane and Nucleoprotein also clustered closely with those of the bat, civet and human SARS coronaviruses. However, the external subdomain of Spike's receptor binding domain of 2019-nCoV shares only 40% amino acid identity with other SARS-related coronaviruses. Remarkably, its orf3b encodes a completely novel short protein. Furthermore, its new orf8 likely encodes a secreted protein with an alpha-helix, following with a beta-sheet(s) containing six strands. Learning from the roles of civet in SARS and camel in MERS, hunting for the animal source of 2019-nCoV and its more ancestral virus would be important for understanding the origin and evolution of this novel lineage B betacoronavirus. These findings provide the basis for starting further studies on the pathogenesis, and optimizing the design of diagnostic, antiviral and vaccination strategies for this emerging infection."],"journal":"Emerg Microbes Infect","authors":["Chan, Jasper Fuk-Woo","Kok, Kin-Hang","Zhu, Zheng","Chu, Hin","To, Kelvin Kai-Wang","Yuan, Shuofeng","Yuen, Kwok-Yung"],"date":"2020-01-29T11:00:00Z","year":2020,"_id":"31987001","week":"20205|Jan 27 - Feb 02","doi":"10.1080/22221751.2020.1719902","keywords":["coronavirus","sars","wuhan","bioinformatics","emerging","genome","respiratory","virus"],"link_erratum_in":"32133926","source":"PubMed","topics":["Mechanism"],"weight":1,"locations":["Wuhan","China","Wuhan"],"countries":["China"],"countries_codes":["CHN|China"],"_version_":1664640875414683650,"score":221.54878},{"pmid":32330208,"title":"Machine learning using intrinsic genomic signatures for rapid classification of novel pathogens: COVID-19 case study.","text":["Machine learning using intrinsic genomic signatures for rapid classification of novel pathogens: COVID-19 case study.","The 2019 novel coronavirus (renamed SARS-CoV-2, and generally referred to as the COVID-19 virus) has spread to 184 countries with over 1.5 million confirmed cases. Such major viral outbreaks demand early elucidation of taxonomic classification and origin of the virus genomic sequence, for strategic planning, containment, and treatment. This paper identifies an intrinsic COVID-19 virus genomic signature and uses it together with a machine learning-based alignment-free approach for an ultra-fast, scalable, and highly accurate classification of whole COVID-19 virus genomes. The proposed method combines supervised machine learning with digital signal processing (MLDSP) for genome analyses, augmented by a decision tree approach to the machine learning component, and a Spearman's rank correlation coefficient analysis for result validation. These tools are used to analyze a large dataset of over 5000 unique viral genomic sequences, totalling 61.8 million bp, including the 29 COVID-19 virus sequences available on January 27, 2020. Our results support a hypothesis of a bat origin and classify the COVID-19 virus as Sarbecovirus, within Betacoronavirus. Our method achieves 100% accurate classification of the COVID-19 virus sequences, and discovers the most relevant relationships among over 5000 viral genomes within a few minutes, ab initio, using raw DNA sequence data alone, and without any specialized biological knowledge, training, gene or genome annotations. This suggests that, for novel viral and pathogen genome sequences, this alignment-free whole-genome machine-learning approach can provide a reliable real-time option for taxonomic classification.","PLoS One","Randhawa, Gurjit S","Soltysiak, Maximillian P M","El Roz, Hadi","de Souza, Camila P E","Hill, Kathleen A","Kari, Lila","32330208"],"abstract":["The 2019 novel coronavirus (renamed SARS-CoV-2, and generally referred to as the COVID-19 virus) has spread to 184 countries with over 1.5 million confirmed cases. Such major viral outbreaks demand early elucidation of taxonomic classification and origin of the virus genomic sequence, for strategic planning, containment, and treatment. This paper identifies an intrinsic COVID-19 virus genomic signature and uses it together with a machine learning-based alignment-free approach for an ultra-fast, scalable, and highly accurate classification of whole COVID-19 virus genomes. The proposed method combines supervised machine learning with digital signal processing (MLDSP) for genome analyses, augmented by a decision tree approach to the machine learning component, and a Spearman's rank correlation coefficient analysis for result validation. These tools are used to analyze a large dataset of over 5000 unique viral genomic sequences, totalling 61.8 million bp, including the 29 COVID-19 virus sequences available on January 27, 2020. Our results support a hypothesis of a bat origin and classify the COVID-19 virus as Sarbecovirus, within Betacoronavirus. Our method achieves 100% accurate classification of the COVID-19 virus sequences, and discovers the most relevant relationships among over 5000 viral genomes within a few minutes, ab initio, using raw DNA sequence data alone, and without any specialized biological knowledge, training, gene or genome annotations. This suggests that, for novel viral and pathogen genome sequences, this alignment-free whole-genome machine-learning approach can provide a reliable real-time option for taxonomic classification."],"journal":"PLoS One","authors":["Randhawa, Gurjit S","Soltysiak, Maximillian P M","El Roz, Hadi","de Souza, Camila P E","Hill, Kathleen A","Kari, Lila"],"date":"2020-04-25T11:00:00Z","year":2020,"_id":"32330208","week":"202017|Apr 20 - Apr 26","doi":"10.1371/journal.pone.0232391","source":"PubMed","topics":["Mechanism"],"weight":1,"locations":["Sarbecovirus"],"_version_":1664996914871926785,"score":201.6141},{"pmid":32108862,"pmcid":"PMC7112083","title":"Genome Detective Coronavirus Typing Tool for rapid identification and characterization of novel coronavirus genomes.","text":["Genome Detective Coronavirus Typing Tool for rapid identification and characterization of novel coronavirus genomes.","SUMMARY: Genome Detective is a web-based, user-friendly software application to quickly and accurately assemble all known virus genomes from next generation sequencing datasets. This application allows the identification of phylogenetic clusters and genotypes from assembled genomes in FASTA format. Since its release in 2019, we have produced a number of typing tools for emergent viruses that have caused large outbreaks, such as Zika and Yellow Fever Virus in Brazil. Here, we present The Genome Detective Coronavirus Typing Tool that can accurately identify the novel severe acute respiratory syndrome (SARS) related coronavirus (SARS-CoV-2) sequences isolated in China and around the world. The tool can accept up to 2,000 sequences per submission and the analysis of a new whole genome sequence will take approximately one minute. The tool has been tested and validated with hundreds of whole genomes from ten coronavirus species, and correctly classified all of the SARS-related coronavirus (SARSr-CoV) and all of the available public data for SARS-CoV-2. The tool also allows tracking of new viral mutations as the outbreak expands globally, which may help to accelerate the development of novel diagnostics, drugs and vaccines to stop the COVID-19 disease. AVAILABILITY: https://www.genomedetective.com/app/typingtool/cov. SUPPLEMENTARY INFORMATION: Supplementary data are available at Bioinformatics online.","Bioinformatics","Cleemput, Sara","Dumon, Wim","Fonseca, Vagner","Karim, Wasim Abdool","Giovanetti, Marta","Alcantara, Luiz Carlos","Deforche, Koen","de Oliveira, Tulio","32108862"],"abstract":["SUMMARY: Genome Detective is a web-based, user-friendly software application to quickly and accurately assemble all known virus genomes from next generation sequencing datasets. This application allows the identification of phylogenetic clusters and genotypes from assembled genomes in FASTA format. Since its release in 2019, we have produced a number of typing tools for emergent viruses that have caused large outbreaks, such as Zika and Yellow Fever Virus in Brazil. Here, we present The Genome Detective Coronavirus Typing Tool that can accurately identify the novel severe acute respiratory syndrome (SARS) related coronavirus (SARS-CoV-2) sequences isolated in China and around the world. The tool can accept up to 2,000 sequences per submission and the analysis of a new whole genome sequence will take approximately one minute. The tool has been tested and validated with hundreds of whole genomes from ten coronavirus species, and correctly classified all of the SARS-related coronavirus (SARSr-CoV) and all of the available public data for SARS-CoV-2. The tool also allows tracking of new viral mutations as the outbreak expands globally, which may help to accelerate the development of novel diagnostics, drugs and vaccines to stop the COVID-19 disease. AVAILABILITY: https://www.genomedetective.com/app/typingtool/cov. SUPPLEMENTARY INFORMATION: Supplementary data are available at Bioinformatics online."],"journal":"Bioinformatics","authors":["Cleemput, Sara","Dumon, Wim","Fonseca, Vagner","Karim, Wasim Abdool","Giovanetti, Marta","Alcantara, Luiz Carlos","Deforche, Koen","de Oliveira, Tulio"],"date":"2020-02-29T11:00:00Z","year":2020,"_id":"32108862","week":"20209|Feb 24 - Mar 01","doi":"10.1093/bioinformatics/btaa145","source":"PubMed","topics":["Treatment","Diagnosis","Mechanism"],"weight":1,"locations":["Zika","Brazil","China","Bioinformatics"],"countries":["China","Brazil"],"countries_codes":["CHN|China","BRA|Brazil"],"_version_":1664640875099062272,"score":195.51787}]}